期刊文献+

RNAi沉默Cripto基因对结肠癌细胞血管内皮生长因子的抑制 被引量:11

Effects of inhibition of Cripto gene siRNA on vascular endothelial growth factor of colon cancer cell line LS-174T
下载PDF
导出
摘要 目的:研究Cripto基因对结肠癌细胞血管内皮生长因子的影响。方法:设计合成针对Cripto基因的小干扰RNA(small interfering RNA,siRNA),转染结肠癌LS-174T细胞。细胞分4组:空载对照组(对照组)和不同浓度(3.125、6.25和12.5 nmol/L)的siRNA组。分别于转染24、48、72 h后收集细胞,以实时定量PCR检测结肠癌细胞CriptomRNA,分别采用Northern blotting和免疫荧光标记法检测癌细胞VEGF mRNA和蛋白表达。分别收集转染72 h的12.5 nmol/L组和对照组细胞,接种于裸鼠背部。30 d后处死裸鼠,收集裸鼠肿瘤组织,对组织VEGF进行免疫组化染色,计算染色平均强度。结果:实时定量PCR检测显示,转染组CriptomRNA被有效地抑制,且呈浓度和时间依赖性。转染组细胞VEGF蛋白和mRNA明显低于对照组。裸鼠肿瘤免疫组化分析显示,转染组VEGF平均染色强度明显低于对照组。结论:Cripto基因参与了结肠癌组织血管生成的调控。采用siRNA下调Cripto基因表达,可抑制结肠癌组织血管生成。 AIM: To study the effects of Cripto gene on vascular endothelial growth factor (VEGF) of colon carcinoma cells. METHODS: Cripto siRNA was designed and constructed. Colon cancer LS - 174T cells were divided into 4 groups: control group and different dose (3. 125, 6. 25 and 12. 5 nmol/L) of siRNA groups. After transfected for 24, 48 and 72 h, colon cancer ceils were harvested to carry on the next tests. Expression of Cripto mRNA was determined with real -time PCR, and immunofluorescence isothiocyanate (FITC) labeling assay and Northern blotting were performed to examine the expression of protein and mRNA of VEGF, respectively. The cells in control group and cells transfected with 12. 5 nmol/L siRNA were inoculated into nude mice respectively. 30 days after inoculated, the mice of two groups were executed, and immunohistochemical (ICH) assay was used to evaluate the VEGF protein of mice tumor. RESULTS: siRNA down - regulated the Cripto mRNA in a dose and time dependent manner. Protein and mRNA of VEGF in transfected cells reduced in a dose and time dependent manner. Compared to control, the expression of VEGF protein from ICH assay was lowered significantly ( P 〈 0.05). CONCLUSION : Cripto gene might contribute to the regulation of angiogenesis of colon carcinoma. The down - regulation of Cripto gene by siRNA can suppress angiogenesis of human colon cancer.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2008年第2期242-245,共4页 Chinese Journal of Pathophysiology
基金 中国博士后基金项目(No.2003033547) 镇江市科技计划项目(No.SH2006019)
关键词 结肠肿瘤 基因 CRIPTO RNA干扰 SIRNA 血管内皮生长因子 Colonic neoplasms Genes, Cripto RNA interence siRNA Vascular endothelial growth factors
  • 相关文献

参考文献12

  • 1Arii S, Ishigami S, Mori A, et al. Implication of VEGF and MMPs in hepatic metastasis of human colon cancer [J]. Nippon Geka Gakkai Zasshi, 1998,99 (7) :436 - 440.
  • 2Widel MS, Widel M. Mechanisms of metastasis and molecular markers of malignant tumor progression. Ⅰ Colorectal cancer [ J ]. Postepy Hig Med Dosw, 2006,60 : 453 - 470.
  • 3Adamson ED, Minchiotti G, Salomon DS. Cripto: a tumor growth factor and more[ J]. J Cell Physiol,2002, 190(3) : 267 - 278.
  • 4Xing PX, Hu XF, Pietersz GA, et al. Cripto: a novel target for antibody- based cancer immunotherapy[ J]. Cancer Res, 2004,64( 11 ) :4018 -4023.
  • 5Normanno N, De Luca A, Salomon DS, et al. Epidermal growth factor- related peptides as targets for experimental therapy of human colon carcinoma [ J ]. Cancer Detect Prey, 1998,22( 1 ) :62 - 67.
  • 6De Angelis E, Grassi M, Gullick WJ, et al. Expression of Cripto and amphiregulin in colon mucosa from high risk colon cancer families[ J ]. Int J Oncol, 1999,14 (3) :437 -440.
  • 7范钰,郑树,丁佳逸.脂质体介导的cripto反义寡核苷酸抑制结肠癌细胞端粒酶活性[J].中国病理生理杂志,2006,22(4):762-765. 被引量:42
  • 8Favier J,Plouin PF,Corvol P,et al. Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors [ J ]. Am J Pathol, 2002, 161 (4) : 1235 - 1246.
  • 9McCabe CJ, Boelaert K, Tannahill LA, et al. Vascular endothelial growth factor, its receptor KDR/Flk - 1, and pituitary tumor transforming gene in pituitary tumors [ J ]. J Clin Endocrinol Metab, 2002,87 (9):4238 - 4244.
  • 10Schoppmann SF, Birner P,Stockl J, et al. Tumor - associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphan giogenesis [J]. Am J Pathol,2002,161(3) :947 -956.

二级参考文献15

  • 1张海伟,罗英儒,郑佩娥,文剑明.蛋白激酶C的活性变化对人肝癌细胞增殖及端粒酶表达的影响[J].中国病理生理杂志,2004,20(7):1176-1178. 被引量:3
  • 2Adamson ED,Minchiotti G,Salomon DS.Cripto:a tumor growth factor and more[J].J Cell Physiol,2002,190(3):267-278.
  • 3Ciardiello F,Kim N,Saeki T,et al.Differential expression of epidermal growth factor-related proteins in human colorectal tumors[J].Proc Natl Acad Sci USA,1991,88(17):7792 -7796.
  • 4Normanno N,De Luca A,Salomon DS,et al.Epidermal growth factor-related peptides as targets for experimental therapy of human colon carcinoma[J].Cancer Detect Prey,1998,22(1):62-67.
  • 5De Angelis E,Grassi M,Gullick WJ,et al.Expression of cripto and amphiregulin in colon mucosa from high risk colon cancer families[J].Int J Oncol,1999,14(3):437-440.
  • 6Baldassarre G,Tucci M,Lembo G,et al.A truncated form of teratocarcinoma-derived growth factor-1 (cripto-1) mRNA expressed in human colon carcinoma cell lines and tumors[J].Tumour Biol,2001,22(5):286-293.
  • 7Tang R,Cheng AJ,Wang JY,et al.Close correlation between telomerase expression and adenomatous polyp progression in multistep colorectal carcinogenesis[ J ].Cancer Res,1998,58(18):4052-4054.
  • 8Engelhardt M,Drullinsky P,Guillem J,et al.Telomerase and telomere length in the development and progression of premalignant lesions to colorectal cancer[J].Clin Cancer Res,1997,3(11):1931-1941.
  • 9Mizumoto I,Ogawa Y,Niiyama H,et al.Possible role of telomerase activation in the multistep tumor progression of periampullary lesions in patients with familial adenomatous polyposis[J].Am J Gastroenterol,2001,96(4):1261-1265.
  • 10Boldrini L,Faviana P,Gisfredi S,et al.Evaluation of telomerase in the development and progression of colon cancer[J].Int J Mol Med,2002,10(5):589-592.

共引文献41

同被引文献119

引证文献11

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部